Department of Endocrinology, the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Department of Endocrinology, National Regional Medical Center, the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Front Endocrinol (Lausanne). 2024 May 30;15:1357294. doi: 10.3389/fendo.2024.1357294. eCollection 2024.
To investigate the correlation between vibration sensory threshold (VPT) and renal function, including glomerulus and renal tubule, in patients with type 2 diabetes mellitus (T2DM).
A total of 1274 patients with T2DM who were enrolled in the Department of Endocrinology of the First Affiliated Hospital of Fujian Medical University between January 2017 and June 2020 were included. Patients were grouped according to VPT levels and divided into three groups, including the normal VPT group (VPT<15V), the mild-moderate elevated VPT group (VPT15~25V), and the severely elevated VPT group (VPT≥25 V). Linear correlation analysis was used to analyze the correlation between VPT and renal functions, including glomerulus markers urine microalbumin (MA) and urinary immunoglobulin G (U-IgG), and renal tubule marker α1-microglobulin (α1-MG). Chronic kidney disease (CKD) was defined according to Kidney Disease Improving Global Outcomes (KDIGO) criteria. The binary logistic regression of the relation between VPT and CKD, eGFR<60 ml/min, and UACR >30 mg/g were expressed.
In the mild-moderate and severely elevated VPT group, injury biomarkers of glomerulus (MA and U-IgG), renal tubule (α1-MG), and the incidence of CKD, eGFR<60 ml/min, and UACR > 30 mg/g were gradually increased compared with the normal VPT group. Furthermore, patients with diabetes and severely elevated VPT had significantly higher levels of MA (β=197.54, p=0.042) and α1-MG (β=11.69, p=0.023) compared to those with normal VPT. Also, patients with mild-moderate elevated VPT demonstrate significantly higher levels of MA (β=229.02, p=0.005). Patients in mild-moderate elevated VPT group (OR=1.463, 95% CI 1.005-2.127; OR=1.816, 95% CI 1.212-2.721) and severely elevated VPT group (OR=1.704, 95% CI 1.113-2.611; OR=2.027, 95% CI 1.248-3.294) are at a higher incidence of CKD and elevated levels of UACR>30mg/g compared to those in the VPT normal group. Moreover, the incidence of positive Upro was notably higher in the severely elevated VPT group (OR=1.738, 95% CI 1.182-2.556). However, this phenomenon was not observed in the incidence of eGFR <60 ml/min.
A higher VPT is positively associated with the incidence of CKD in patients with T2DM, particularly with elevated UACR. VPT may serve as a marker for glomerulus and renal tubule injury.
探讨 2 型糖尿病(T2DM)患者振动感觉阈值(VPT)与肾小球和肾小管功能的相关性。
选取 2017 年 1 月至 2020 年 6 月在福建医科大学附属第一医院内分泌科就诊的 T2DM 患者 1274 例。根据 VPT 水平将患者分为三组:正常 VPT 组(VPT<15V)、轻度至中度升高 VPT 组(VPT15~25V)和重度升高 VPT 组(VPT≥25V)。采用线性相关分析 VPT 与肾小球标志物尿微量白蛋白(MA)和尿免疫球蛋白 G(U-IgG)、肾小管标志物α1-微球蛋白(α1-MG)等肾功标志物之间的相关性。根据肾脏疾病改善全球结局(KDIGO)标准定义慢性肾脏病(CKD)。用二元逻辑回归分析 VPT 与 CKD、eGFR<60ml/min 和 UACR>30mg/g 之间的关系。
在轻度至中度升高和重度升高 VPT 组中,肾小球损伤标志物(MA 和 U-IgG)、肾小管损伤标志物(α1-MG)、CKD、eGFR<60ml/min 和 UACR>30mg/g 的发生率逐渐升高,与正常 VPT 组相比差异有统计学意义。此外,与正常 VPT 组相比,重度升高 VPT 患者的 MA(β=197.54,p=0.042)和 α1-MG(β=11.69,p=0.023)水平显著升高。同时,轻度至中度升高 VPT 患者的 MA 水平也显著升高(β=229.02,p=0.005)。与正常 VPT 组相比,轻度至中度升高 VPT 组(OR=1.463,95%CI 1.005-2.127;OR=1.816,95%CI 1.212-2.721)和重度升高 VPT 组(OR=1.704,95%CI 1.113-2.611;OR=2.027,95%CI 1.248-3.294)的 CKD 发生率和 UACR>30mg/g 水平显著升高。此外,重度升高 VPT 组的 Upro 阳性率明显升高(OR=1.738,95%CI 1.182-2.556)。然而,在 eGFR<60ml/min 的发生率方面,没有观察到这种现象。
较高的 VPT 与 T2DM 患者 CKD 的发生呈正相关,尤其与 UACR 升高有关。VPT 可能是肾小球和肾小管损伤的标志物。